Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO study (Q43503861)
Jump to navigation
Jump to search
scientific article published on 7 May 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO study |
scientific article published on 7 May 2012 |
Statements
1 reference
Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO study (English)
1 reference
Isabelle Ray-Coquard
1 reference
Thomas Bachelot
1 reference
Céline Bourgier
1 reference
Claire Cropet
1 reference
Jean-Marc Ferrero
1 reference
Sophie Abadie-Lacourtoisie
1 reference
Jean-Christophe Eymard
1 reference
Marc Debled
1 reference
Dominique Spaëth
1 reference
Eric Legouffe
1 reference
Djelila Allouache
1 reference
Claude El Kouri
1 reference
Eric Pujade-Lauraine
1 reference
7 May 2012
1 reference
1 reference
Identifiers
1 reference